Healthbit’s dementia app is the world’s first clinically evidenced app for patients with mild dementia or mild cognitive impairment (MCI) and their carers.
Evidenced through a ground-breaking randomised control trial (RCT), the app has been shown to benefit people living with dementia and their carers in a number of ways. The RCT was conducted over a 2 year period, across 4 sites in 3 countries and involved over 1000 people living with dementia and their carers.
The clinical data concluded multiple benefits, including;
Significant improvement in Quality of Life for the person living with dementia
Significant reduction in carer stress and depression
The more the application is used, the greater the positive impact
Background
Study
A pragmatic, multi-centre RCT following the Consolidated Standards of Reporting Trials (CONSORT). The ClinicalTrials.gov identifier: NCT03325699.
Setting
Four participant centres: Consorci Sanitari de Terrassa (Catalonia, Spain), Servicio Andaluz de Salud (Andalusia, Spain), Blekinge Institute of Technology (Sweden), and University College Leuven-Limburg (Belgium).
Useful Links